This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Synapses of the reward system at stake in ... Autism spectrum disorders are a heterogeneous group of ... (07 Aug 2018)
  A diverse diet may not be the healthiest ... Encouraging people to eat a wide variety of foods to ensure they ... (07 Aug 2018)
Older adults who get physical can lower ... Adults in their early 60s, who spend less time sitting and more ... (07 Aug 2018)
People who sleep for more than eight hours ... A large study led by Keele University has found that sleeping ... (07 Aug 2018)
Learning while sleeping? Our learning ... A group of researchers found that our learning capabilities are ... (07 Aug 2018)
Saturday, 21 April 2018 09:32

Clinical Evaluation of a Patient with Asymptomatic Severe Aortic Stenosis Featured

Rate this item
(0 votes)

In the current issue of Cardiovascular Innovations and Applications (Volume2, Number 4, 2018, pp421-424(4), researchers Jared G. Breyley and Brian R. Lindman, from Vanderbilt University Medical Center, Nashville, TN, USA present a case study of asymptomatic severe aortic stenosis.

Aortic stenosis (AS) is one of the most common valvular diseases, with a prevalence of 3.4% in adults older than 75 years. AS is considered a surgical disease in that the only treatment known to reduce mortality is AVR, by either a surgical or a transcatheter approach. While current guidelines provide clear evidence-based recommendations for treatment of symptomatic patients, it remains less clear how to treat patients with severe AS who are asymptomatic. This case describes an elderly man without a significant medical history who was found to have severe AS. The patient reported no symptoms, had no evidence of heart failure on PE, and was noted to be physically active.

The case presented an older man without a significant medical history who was found to have severe AS without any apparent symptoms. If the history is convincing and detailed regarding the extent of exertion without change over a sustained period, many clinicians may not pursue a stress test for confirmation. However, if there is any doubt regarding the history (and, in most cases, there is some doubt), further evaluation with an ETT should be pursued. If the ETT findings are normal, there remains clinical equipoise for whether or not early AVR should be performed. Beyond stress testing, looking for additional “flags of risk” will be helpful to inform the decision regarding the timing of AVR. These flags may include very severe AS, rapid progression, an elevated natriuretic peptide level, the presence of myocardial fibrosis, marked LVH, or exercise-induced pulmonary hypertension.

Advocates for AVR in the asymptomatic patient contend that valve replacement is inevitable and that we are only waiting for bad things to happen (e.g., sudden death, myocardial dysfunction). Unloading the heart with valve replacement sooner will prevent ongoing damage to myocardial structure and function, which may optimize long-term heart function and freedom from heart failure. Even with close follow-up, symptom onset can occur suddenly and be quite severe. Progressive improvements in operative and postoperative care and the introduction of less invasive ways to replace the valve have decreased the risks of intervention.

Nonetheless, complications, including stroke and death, occur as a result of AVR. Further, the implantation of a valve prosthesis introduces the possibility of valve dysfunction and degeneration, with associated morbidity and death. Both sides of this dilemma regarding the optimal timing of AVR for asymptomatic patients have been widely debated and advocated in the literature.


Source: Compuscript Ltd
Full bibliographic information
Clinical Evaluation of a Patient with Asymptomatic Severe Aortic Stenosis, Jared G. Breyley and Brian R. Lindman, Cardiovascular Innovations and Applications, Volume2, Number 4, 2018, pp421-424(4); DOI: https://doi.org/10.15212/CVIA.2017.0022

 

Read 224 times Last modified on Saturday, 21 April 2018 11:02

TheSynapse Videos

0
0
0
0
0
0

Latest news

Highlights

  • Interactive Discussion on Valsartan

     

     

    The Malta Medicines Authority in collaboration with the Superintendence
    of Public Health and the Department of Pharmacy University of Malta
    would like to cordially invite you to an interactive scientific discussion:

     

     


    THE VALSARTAN SAGA


    SCIENCE | MYTHS | REALITIES

     


    led by Professor Anthony Serracino Inglott

     


    Date: Wednesday 25 July 2018

     


    Time: 20:00
    Venue: Conference Room, Life Sciences Park, San Ġwann

     


    Refreshments will be served


    RSVP: info.medicinesauthority@gov.mt | 23439202

    Written on July 21, 2018
  • Les Laboratoires Servier - Job Vacancy
    Written on June 29, 2018 Read more...

Join

Connect with other Medical Professionals on fb in a closed facebook group

captcha  

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…